RUSSIAN DIRECT INVESTMENT FUND
Sputnik Light COVID-19 Vaccine Approval in India Major Step in Bilateral Cooperation Against Coronavirus, Says RDIF CEO Kirill Dmitriev
Sputnik V COVID-19 Vaccine Shows Higher Omicron-Specific Antibodies Than Pfizer: Study
COVID-19 Vaccines for Adolescents: RDIF Ready To Provide One-Shot Sputnik Light Vaccine, Sputnik M Vaccine to India
Sputnik V, Sputnik Light Will Neutralise Latest COVID-19 Variant Omicron, Says RDIF
Sputnik V Vaccine Update: RDIF, SII to Start Production of Sputnik V COVID-19 Vaccine in India from September
COVID-19 Vaccine Sputnik V to Offer Booster Shot Against Delta Variant to Other Vaccine Manufacturers
Russia’s Single-Dose Sputnik Light COVID-19 Vaccine Has 79.4% Efficacy, Effective Against All New Coronavirus Strains: RDIF
Dr Reddy's Laboratories Gets Authorisation from DCGI to Import Russian COVID-19 Vaccine Sputnik V in India
Sputnik V Approved by DGCI for Emergency Use Authorisation; India to Produce 850 Million Doses of Russian COVID-19 Vaccine, Says RDIF
Sputnik V, Russain COVID-19 Vaccine, Approved by Drug Controller General of India, Says RDIF
Sputnik V COVID-19 Vaccine Approved For Emergency Use Authorisation; Know All About Russian Coronavirus Vaccine Being Manufactured by Dr Reddy's and Panacea Biotec in India
RDIF, Panacea Biotec To Produce 100 Million Doses of ‘Sputnik V’ COVID-19 Vaccine in India per Year
Google Trends